Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (1): 31-35.doi: 10.3969/j.issn.1000-6621.2021.01.007
• Original Articles • Previous Articles Next Articles
ZENG Jian-feng, YANG Min, TANG Fang, ZHU Hui-min, CHEN Tao, DENG Guo-fang, ZHANG Pei-ze()
Received:
2020-12-07
Online:
2021-01-10
Published:
2021-01-12
Contact:
ZHANG Pei-ze
E-mail:peizezhang@aliyun.com
ZENG Jian-feng, YANG Min, TANG Fang, ZHU Hui-min, CHEN Tao, DENG Guo-fang, ZHANG Pei-ze. Clinical characteristics of pulmonary tuberculosis in hospitalized patients with diabetes mellitus[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 31-35. doi: 10.3969/j.issn.1000-6621.2021.01.007
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.01.007
项目类别 | 活动性肺结核组 (31例) | 非活动性肺结核组 (32例) | 未发现异常 (2585例) | 合计 (2648例) | |||
---|---|---|---|---|---|---|---|
性别 | |||||||
男 | 28(90.32) | 27(84.38) | 1663(64.33) | 1718(64.88) | |||
女 | 3(9.68) | 5(15.62) | 922(35.67) | 930(35.12) | |||
年龄组(岁) | |||||||
15~ | 1(3.23) | 0(0.00) | 24(0.93) | 25(0.94) | |||
26~ | 3(9.68) | 0(0.00) | 177(6.85) | 180(6.80) | |||
36~ | 8(25.81) | 3(9.37) | 464(17.95) | 475(17.94) | |||
46~ | 5(16.13) | 10(31.25) | 739(28.59) | 754(28.47) | |||
56~ | 9(29.03) | 5(15.63) | 644(24.91) | 658(24.85) | |||
66~ | 4(12.90) | 8(25.00) | 364(14.08) | 376(14.20) | |||
76~ | 1(3.23) | 6(18.75) | 150(5.80) | 157(5.93) | |||
86~95 | 0(0.00) | 0(0.00) | 23(0.89) | 23(0.87) | |||
并发其他疾病 | |||||||
高血压 | 6(19.35) | 20(62.50) | 1231(47.62) | 1257(47.47) | |||
冠心病 | 4(12.90) | 8(25.00) | 386(14.93) | 398(15.03) | |||
慢性乙型病毒性肝炎 | 6(19.35) | 3(9.38) | 215(8.32) | 224(8.46) | |||
肝硬化 | 0(0.00) | 0(0.00) | 40(1.55) | 40(1.51) | |||
终末期肾病 | 1(3.23) | 0(0.00) | 11(0.43) | 12(0.45) | |||
恶性肿瘤 | 0(0.00) | 6(18.75) | 233(9.01) | 239(9.03) | |||
风湿性疾病 | 0(0.00) | 1(3.13) | 72(2.79) | 73(2.76) | |||
器官移植 | 0(0.00) | 0(0.00) | 5(0.19) | 5(0.19) |
临床资料 | 活动性肺结核组 (31例) | 非活动性肺结核组 (32例) | 统计检验值 | P值 |
---|---|---|---|---|
性别[例数(构成比,%)] | χ2=-0.502 | 0.478 | ||
男 | 28(90.32) | 27(84.38) | ||
女 | 3(9.68) | 5(15.62) | ||
平均年龄(岁, | 51.16±13.06 | 61.78±12.88 | t=-3.236 | 0.002 |
糖化血红蛋白(HbA1c)(%, | 9.18±2.85 | 8.05±1.69 | t=1.884 | 0.070 |
血白蛋白(g/L, | 39.18±5.32 | 39.66±4.34 | t=-0.408 | 0.685 |
并发其他疾病[例数(比率,%)] | χ2=11.535 | 0.420 | ||
高血压 | 6(19.35) | 20(62.50) | ||
冠心病 | 4(12.90) | 8(25.00) | ||
慢性乙型病毒性肝炎 | 6(19.35) | 3(9.38) | ||
终末期肾病 | 1(3.23) | 0(0.00) | ||
恶性肿瘤 | 0(0.00) | 6(18.75) | ||
风湿性疾病 | 0(0.00) | 1(3.13) | ||
糖尿病治疗情况[例数(构成比,%)] | χ2=1.520 | 0.823 | ||
首发,未开始治疗 | 6(19.35) | 8(25.00) | ||
无治疗 | 4(12.90) | 2(6.25) | ||
口服药品治疗 | 10(32.27) | 8(25.00) | ||
胰岛素注射治疗 | 4(12.90) | 5(15.63) | ||
联合治疗 | 7(22.58) | 9(28.12) |
[1] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[2] |
Misra A, Gopalan H, Jayawardena R, et al. Diabetes in develo-ping countries. J Diabetes. 2019,11(7):522-539. doi: 10.1111/1753-0407.12913.
doi: 10.1111/1753-0407.12913 URL pmid: 30864190 |
[3] | Lin Y, Harries AD, Kumar AMV, et al. Management of diabetes mellitus-tuberculosis: a guide to the essential practice. Paris: International Union Against Tuberculosis and Lung Disease, World Diabetes Foundation, 2019. |
[4] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017 肺结核诊断. 2017-11-09. |
[5] | 陈红光, 刘民, 顾芳慧. 中国大陆地区肺结核合并糖尿病患病率的Meta分析. 中华流行病学杂志, 2013,34(11):1128-1133. doi: 10.3760/cma.j.issn.0254-6450.2013.011.019. |
[6] | 《中国糖尿病防治指南》编写组. 中国糖尿病防治指南, 北京: 北京大学医学出版社, 2004: 11-12. |
[7] | 国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识. 中国防痨杂志, 2020,42(4):301-307. doi: 10.3969/j.issn.1000-6621.2020.04.001. |
[8] |
Cheng J, Zhang H, Zhao YL, et al. Mutual Impact of Diabetes Mellitus and Tuberculosis in China. Biomed Environ Sci, 2017,30(5):384-389. doi: 10.3967/bes2017.051.
doi: 10.3967/bes2017.051 URL pmid: 28549496 |
[9] |
Jeon CY, Harries AD, Baker MA, et al. Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health, 2010,15(11):1300-1314. doi: 10.1111/j.1365-3156.2010.02632.x.
doi: 10.1111/j.1365-3156.2010.02632.x URL pmid: 20958887 |
[10] |
Martinez N, Kornfeld H. Tuberculosis and diabetes: from bench to bedside and back. Int J Tuberc Lung Dis, 2019,23(6):669-677. doi: 10.5588/ijtld.18.0805.
doi: 10.5588/ijtld.18.0805 URL pmid: 31315698 |
[11] |
Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health, 2012,17(10):1302-1308. doi: 10.1111/j.1365-3156.2012.03069.x.
doi: 10.1111/j.1365-3156.2012.03069.x URL |
[12] | 汪娟, 许缃, 姜静, 等. 2013—2017年上海市徐汇区糖尿病并发肺结核患者特征登记转归分析. 结核病与肺部健康杂志, 2019,8(1):29-32. doi: 10.3969/j.issn.2095-3755.2019.01.008. |
[13] | 汪娟, 许缃, 蔡晓峰, 等. 对糖尿病患者进行肺结核筛查的效果与成本效益分析. 中国防痨杂志, 2019,41(9):968-973. doi: 10.3969/j.issn.1000-6621.2019.09.011. |
[14] |
Ji Y, Cao H, Liu Q, et al. Screening for pulmonary tuberculosis in high-risk groups of diabetic patients. Int J Infect Dis, 2020,93:84-89. doi: 10.1016/j.ijid.2020.01.019.
doi: 10.1016/j.ijid.2020.01.019 URL pmid: 31978585 |
[15] |
Paton NI, Borand L, Benedicto J, et al. Diagnosis and mana-gement of latent tuberculosis infection in Asia: Review of current status and challenges. Int J Infect Dis, 2019,87:21-29. doi: 10.1016/j.ijid.2019.07.004.
doi: 10.1016/j.ijid.2019.07.004 URL pmid: 31301458 |
[16] |
Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health, 2018,23(10):1058-1070. doi: 10.1111/tmi.13133.
doi: 10.1111/tmi.13133 URL pmid: 30062731 |
[17] |
Jackson C, Southern J, Lalvani A, et al. Diabetes mellitus and latent tuberculosis infection: baseline analysis of a large UK cohort. Thorax, 2019,74(1):91-94. doi: 10.1136/thoraxjnl-2017-211124.
doi: 10.1136/thoraxjnl-2017-211124 URL pmid: 29764958 |
[18] | Lee MR, Huang YP, Kuo YT, et al. Diabetes Mellitus and Latent Tuberculosis Infection: A Systematic Review and Metaanalysis. Clin Infect Dis, 2017,64(6):719-727. doi: 10.1093/cid/ciw836.Erratum in: Clin Infect Dis,2017,65(2):356. |
[19] |
Oglesby W, Kara AM, Granados H, et al. Metformin in tuberculosis: beyond control of hyperglycemia. Infection, 2019,47(5):697-702. doi: 10.1007/s15010-019-01322-5.
doi: 10.1007/s15010-019-01322-5 URL pmid: 31119504 |
[1] | National Clinical Research Center for Infectious Disease/, The Third People’s Hospital of Shenzhen, National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital of Central South University, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Expert consensus on treatment and management of tuberculosis-diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 12-22. |
[2] | HU Wei-hua, JIN Long, CHU Nai-hui. Analysis of drug resistance characteristics of MDR/XDR-TB patients complicated with type 2 diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 26-30. |
[3] | WANG Mei-jie, LI Yu-ze, XIAO Yao, WU Ming-qi, HOU Shao-ying. A comparative study of plasma metabolomics between diabetes and diabetes complicated with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 36-41. |
[4] | LUO Xiao-qing, DUAN Si-yu, LIN Ming-yu, DENG Xun, LIU Bi-fen, LI Lian, TANG Hui-wen, DING Li. Nutritional risk screening and influencial factor analysis in hospitalized patients with comorbidity of tuberculosis and diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 42-46. |
[5] | YANG Min, FU Liang, DENG Guo-fang. Progress in the treatment and management of tuberculosis complicated with diabetes [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 87-90. |
[6] | SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947. |
[7] | DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961. |
[8] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui. Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967. |
[9] | JIANG Li, ZHANG Xiao-qiang, LIU Ling-li, WANG Han, LIU Feng, LI Zhi-yue, SHEN Sheng-rong. Research progress of clinical characteristics of malnourished patients with tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 741-746. |
[10] | XU Yan, LU Xi-wei, CAI Chun-kui, SUN Shi-xue, GU Xiao-feng, YU Yang, LI Gang, WANG Ying. Retrospective study of CT imaging evolution of treatment failure patients with multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 549-557. |
[11] | ZHANG Pei-ze, FU Liang, TAN Jie, WANG Yu-xiang, CHEN Tao, DENG Guo-fang. CT imaging characteristics of cured multidrug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 558-562. |
[12] | LAI Keng, LEI Yu, DU Yu-hua, WU Gui-feng, XIE Wei, SHEN Hong-cheng, ZHONG Zhi-qing, LI Tie-gang. Spatial-temporal analysis on tuberculosis among students in Guangzhou City during 2014-2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 590-596. |
[13] | JIANG Ling, ZENG Wei-feng, TANG Na, LUO Ting-ru, MENG Chang-ping, PENG Yu-jing, QIAN Chun-fang. Clinical characteristics of 15 pregnant women with tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 634-637. |
[14] | BAO Rui, LIU Xiao-yang, REN Peng, ZHANG Feng, LIANG Hai-yan, WANG Ru, FU Ling, GAN Di-shou. Analysis of surgical treatment characteristics in patients with spinal tuberculosis and HIV co-infection [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 645-648. |
[15] | LI Bang-yin, PU Yu, HE Min, HE Lei, HUAN Ming-cang, CAI Yu-guo, LIU Lin, JIANG Xi. Clinical characteristics of HIV-positive spinal tuberculosis patients and effect analysis of strengthening perioperative management [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 449-453. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||